Inventor · disambiguated record
William H. Velander
Also filed as: JOHNSON LEGAL REPRESENTATIVE M · VELANDER WILLIAM · VELANDER WILLIAM H · VELANDER WILLIAM HUGOLD
17 granted patents·6 pending applications·516 citations·filing 1992–2011
95Inventor score
Files withAMERICAN NAT RED CROSS7VIRGINIA TECH INTELL PROP4AMERICAN CROSS & VIRGINIA TECH1CT FOR INNOVATIVE TECHNOLOGY1INNOVATIVE TECH CENTER1
Top patents by PatentIndex Score
23 records- 0198US5880327ATransgenic mammals expressing human coagulation factor VIIIAMERICAN NAT RED CROSS·Filed 1994·Granted Mar 9, 1999·128 cites·42 claims
- 0291US5328603ALignocellulosic and cellulosic beads for use in affinity and immunoaffinity chromatography of high molecular weight proteinsINNOVATIVE TECH CENTER·Filed 1992·Granted Jul 12, 1994·101 cites·8 claims
- 0390US6518482B2Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factorAMERICAN NAT RED CROSS·Filed 2001·Granted Feb 11, 2003·25 cites·32 claims
- 0490US5589604AExpression of human protein C in mammary tissue of transgenic mammalsAMERICAN NAT RED CROSS·Filed 1994·Granted Dec 31, 1996·59 cites·20 claims
- 0587US6344596B1Expression of active human factor IX in mammary tissue and of milk non human transgenic mammalsAMERICAN NAT RED CROSS·Filed 1998·Granted Feb 5, 2002·38 cites·43 claims
- 0685US5523222APolyelectrolyte DNA conjugation and genetic transformation of an animalVIRGINIA TECH INTELL PROP·Filed 1994·Granted Jun 4, 1996·47 cites·14 claims
- 0783US6255554B1Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factorAMERICAN NAT RED CROSS·Filed 1999·Granted Jul 3, 2001·40 cites·44 claims
- 0881US7888321B2Production of high levels of transgenic factor IX without gene rescue, and its therapeutic usesPROGENETICS LLC·Filed 2008·Granted Feb 15, 2011·12 cites·20 claims
- 0975US7419948B2Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammalsAMERICAN NAT RED CROSS·Filed 2005·Granted Sep 2, 2008·4 cites·13 claims
- 1068US5907016AMethod of coupling ligands onto supports and products produced therefromVIRGINIA TECH INTELL PROP·Filed 1994·Granted May 25, 1999·21 cites·57 claims
- 1167US7220718B2Oral treatment of hemophiliaVIRGINIA TECH INTELL PROP·Filed 2002·Granted May 22, 2007·2 cites·28 claims
- 1263US7867974B2Induction of tolerance by oral administration of factor VIII and treatment of hemophiliaUS HEALTH·Filed 2007·Granted Jan 11, 2011·0 cites·20 claims
- 1363US2009221492A1Expression of active human factor ix in mammary tissue of transgenic animalsVELANDER WILLIAM H·Filed 2008·Application pending·0 cites
- 1455US6984772B1Transgenic non-human mammals producing fibrinogen in their milkUNIV NORTH CAROLINA·Filed 1995·Granted Jan 10, 2006·14 cites·38 claims
- 1552US7435869B2Transgenic nonhuman mammals producing fibrinogen in milk and methods of producing fibrinVIRGINA TECH INTELLECTUAL PROP·Filed 2005·Granted Oct 14, 2008·0 cites·30 claims
- 1648US2011283375A1Transgenic Prothrombin And Related Thrombin Precursors And Transgenics, Methods, Compositions, Uses And The Like Relating TheretoVELANDER WILLIAM HUGOLD·Filed 2011·Application pending·0 cites
- 1748US2002166130A1Expression of active human factor IX in mammary tissue of transgenic animalsAMERICAN CROSS & VIRGINIA TECH·Filed 2002·Application pending·0 cites
- 1843US6262336B1Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoterAMERICAN NAT RED CROSS·Filed 1999·Granted Jul 17, 2001·9 cites·29 claims
- 1943US2004133930A1Production of high levels of transgenic factor ix without gene rescue, and its therapeutic usesFiled 2002·Application pending·0 cites
- 2039US5977345AInside-out crosslinked and commercial-scale hydrogels, and sub-macromolecular selective purification using the hyrdogelsVIRGINIA TECH INTELL PROP·Filed 1998·Granted Nov 2, 1999·9 cites·24 claims
- 2136US2004117862A1Production of high levels of transgenic factor VII with engineered stability and its therapeutic usesFiled 2002·Application pending·0 cites
- 2234US6194552B1Immunosorbents with developed binding efficiency and method of manufactureCT FOR INNOVATIVE TECHNOLOGY·Filed 1994·Granted Feb 27, 2001·7 cites·9 claims
- 2325US2002184655A1Methods for the degradation and detoxification of organic material using urine produced by transgenic animals and related transgenic animals and proteinsFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William H. Velander files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →